Lewis David F
Department of Obstetrics and Gynecology, Louisiana State University Health Sciences Center, Shreveport, 71130-3932, USA.
Obstet Gynecol Clin North Am. 2005 Sep;32(3):485-500. doi: 10.1016/j.ogc.2005.03.002.
Magnesium sulfate has become the first-line tocolytic for short-term use to arrest idiopathic preterm labor. The reasons for its acceptance include familiarity of the drug, ease of use, and the virtual absence of serious maternal side effects. Sufficient data exist showing its efficacy if used in higher doses. Attention to treating preterm labor has shifted to seeking answers about the fundamental causes. Gathering information about the specific causes and designing tailor-made treatment protocols for each of the numerous potential causes is essential. Scientifically sound research is needed to obtain answers about the important clinical questions surrounding magnesium sulfate.
硫酸镁已成为短期用于抑制特发性早产的一线宫缩抑制剂。其被接受的原因包括对该药物的熟悉程度、使用便捷性以及几乎不存在严重的母体副作用。有充分的数据表明,高剂量使用时它是有效的。对早产治疗的关注已转向寻找根本原因。收集有关具体原因的信息并为众多潜在原因中的每一个设计量身定制的治疗方案至关重要。需要进行科学合理的研究来获取有关围绕硫酸镁的重要临床问题的答案。